Clinical and prognostic significance of neutrophil-lymphocyte ratio in patients with acute pulmonary embolism

Main Article Content

V. I. Tseluyko
M. V. Kurinna
O. V. Radchenko


The aim – to evaluate the association of neutrophil-lymphocyte ratio (NLR) with the clinical course and hospital prognosis of pulmonary embolism (PE).
Materials and methods. The study included 291 patients with a diagnosis of PE, verified by multislice computed tomographic pulmonary angiography, with a calculated NLR according to clinical blood count. In addition to the standard general-clinical and laboratory-instrumental examination, patients were assessed for risk factors of PE and risk of early death according to ESC 2019 recommendations. The data obtained were statistically processed.
Results and discussion. Patients were divided according to the median NLR: group 1 included 145 patients with NLR <3.4, group 2 – 146 patients with NLR ≥3.4. Also, according to the value of the NLR obtained during the ROC analysis for predicting mortality during the hospital period: group 3 consisted of 245 patients with NLR ≤6.75, group 4 – 46 patients with NLR >6.75. Analyzing demographic indicators, it was found that in group 2, elderly patients (p=0.02) and males (p=0.037) were reliably more common than in group 1. Regardless of the method of division into groups, a reliable predominance of patients at high risk of early death from PE (p<0.001), PESI class V (p<0.01) and high-risk sPESI (p<0.01), with higher PESI scores (p<0.001) was obtained in groups with increased NLR (NLR ≥3.4 and NLR >6.5). In the same groups, analyzing the results of the objective examination, a reliably lower level of saturation (p<0.0001) and SBP (p<0.01) were found. When comparing laboratory parameters, it was found that the average leukocyte levels in the groups with NLR ≥3.4 and NLR >6.5 were reliably higher (p<0.001), and the level of troponin I was reliably increased (p=0.02) only in the group with NLR >6.5. Correlation analysis showed a reliable direct link between the level of NLR and age, heart rate, right atrium (RA) size, LVEDC, mean pulmonary arterial pressure (MPAP), leukocyte and troponin I levels, increased risk of early mortality from PE and hospital mortality, as well as an inverse link with the level of saturation, SBP, LV EF and hemoglobin. 
Conclusions. The link between the level of NLR and clinical and anamnestic parameters in patients with PE was established. Among patients with NLR above the median (≥3.4), elderly patients, males, and high-risk patients with reliably higher PESI scores predominated. A direct correlation between the level of NLR and age, heart rate, RA size, LVEDC, MPAP, leukocyte and troponin I levels, increased risk of early mortality from PE and hospital mortality, as well as an inverse correlation with saturation, SBP, LV EF and hemoglobin levels were established. NLR >6.5 is associated with an unfavorable prognosis – death in the hospital period, as well as with a higher level of troponin I, a marker of right ventricle dysfunction.

Article Details


pulmonary embolism, immunothrombosis, neutrophil-lymphocyte ratio, hospital prognosis


Köse N, Yıldırım T, Akın F, Yıldırım SE, Altun İ. Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism. Bosn J Basic Med Sci. 2020;20(2):248-53.

Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464-74.

Duman D, Sonkaya E, Yıldırım E, Gıdık E, Tanülkü U, Saltürk C, Karakurt Z. Association of Inflammatory Markers with Mortality in Patients Hospitalized with Non-massive Pulmonary Embolism. Turkish Thorac J. 2021;22(1):24.

Özsu SS, Durmuş ZG, Coşkuner MB, Bülbül Y, Öztuna F, Özlü T. Does the Incidence and Mortality of Pulmonary Thromboembolism Change Over the Years? Turk Thorac J. 2017;18(3):78-81.

Yazıcı S, Kırış T, Ceylan US, Şükrü A, Ahmet OU, Recep H, Sait T, Abdullah D, Ayşe E, and Kemal Y. The accuracy of combined use of troponin and red cell distribution width in predicting mortality of patients with acute pulmonary embolism. Wien Klin Wochenschr. 2016;128(Suppl 8):596-603.

Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398(10294):64-77.

Imiela AM, Mikołajczyk TP, Guzik TJ, Pruszczyk P. Acute Pulmonary Embolism and Immunity in Animal Models. Arch Immunol Ther Exp (Warsz). 2024;72(1).

Efros O, Beit Halevi T, Meisel E, Soffer S, Barda N, Cohen O, Kenet G, Lubetsky A. The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients Hospitalized with Acute Pulmonary Embolism. J Clin Med. 2021;10(18):4058.

Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, Joya-Harrison J, Rodriguez D. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians. J Thromb Thrombolysis. 2017;44(3):377-85.

Lv X, Gao X, Liu J, Deng Y, Nie Q, Fan X, Ye Z, Liu P, Wen J. Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study. Front Immunol. 2022;13:1042751.

Li D, Yuan M, Yang H. Blood Cell Parameters Combined with Inflammatory Markers in the Early Diagnosis of Pulmonary Embolism. Cell Mol Biol (Noisy-le-grand). 2022;68(5):177-85.

Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34-45.

Teodoru M, Negrea M, Cozgarea A, Cozma D, Boicean A. Enhancing Pulmonary Embolism Mortality Risk Stratification Using Machine Learning: The Role of the Neutrophil-to-Lymphocyte Ratio. J Clin Med. 2024;13(5).

Cavuş UY, Yildirim S, Sönmez E, Ertan C, Ozeke O. Prognostic value of neutrophil/lymphocyte ratio in patients with pulmonary embolism. Turk J Med Sci. 2014;44(1):50-5.

Teodoru M, Negrea Mo, Cozgarea A, Cozma D, and Boicean A. Enhancing Pulmonary Embolism Mortality Risk Stratification Using Machine Learning: The Role of the Neutrophil-to-Lymphocyte Ratio. Journal of clinical medicine. 2024;13(5).

Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12.

Ates H, Ates I, Kundi H, Yilmaz FM. Diagnostic validity of hematologic parameters in evaluation of massive pulmonary embolism. J Clin Lab Anal. 2017;31(5):e22072.

Alsubhi, Yasir M, Ahmed H, Alhadi, Abdulaziz M. Hammudah, Riyadh A. Alahmadi, Azhar M. Aljohani, Sami Al Dubai, Abdulqader I. Susi, Kholoud Almuwallad, and Turki A. Alwasaidi. Comparison of laboratory biomarkers for the prediction of in-hospital mortality and severity of acute pulmonary embolism: A multi-center study. Saudi Med J. 2023;44(9):898-903.

Phan T, Brailovsky Y, Fareed J, Hoppensteadt D, Iqbal O, Darki A. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism. Clin Appl Thromb Hemost. 2020;26:1076029619900549.

Li R, Shen S, Jiang J, Liu Y. Prognostic value of neutrophil/lymphocyte ratio for pulmonary embolism: a meta-analysis and external validation. Ann Vasc Surg. Published online April 4, 2024:S0890-5096(24)00134-1.

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G-J, Harjola V-P, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603.

Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18(9):666-82.

Soylu K, Gedikli Ö, Ekşi A, Avcıoğlu Y, Soylu Aİ, Yüksel S, Gülel O, Yılmaz Ö. Neutrophil-to-lymphocyte ratio for the assessment of hospital mortality in patients with acute pulmonary embolism. Arch Med Sci. 2016;12(1):95-100.

Kasapoğlu US., Olgun Yıldızeli Ş, Arıkan H, Erer A, Kabadayı F, Yalçınkaya E, Aslan M, Cimşit NÇ, Eryüksel E, Karakurt S. Comparison of neutrophil to lymphocyte ratio with other prognostic markers affecting 30 day mortality in acute pulmonary embolism. Tuberk Toraks. 2019;67(3):179-89.

Elshahaat HA, Zayed NE, Ateya MAM, Safwat M, El Hawary AT, Abozaid MN. Role of serum biomarkers in predicting management strategies for acute pulmonary embolism. Heliyon. 2023;9(11):e21068.

Slajus B, Brailovsky Y, Darwish I, Fareed J, Darki A. Utility of Blood Cellular Indices in the Risk Stratification of Patients Presenting with Acute Pulmonary Embolism. Clin Appl Thromb Hemost. 2021;27:10760296211052292.

Most read articles by the same author(s)

1 2 > >>